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Abstract
Many recent studies have shown that the initiation of human cancer is due to the malfunction
of some genes at the R-checkpoint during the G1-to-S transition of the cell cycle. Identifying
and modeling the dynamics of these genes has a paramount advantage in controlling and, pos-
sibly, treating human cancer. In this study, a new mathematical model for the dynamics of a
cancer sub-network concentration is developed. Positive equilibrium points are determined and
rigorously analyzed. We have found a condition for the existence of the positive equilibrium
points from the activation, inhibition and degradation parameter values of the dynamical sys-
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In this chapter, first we define systems biology and present some of the key biological concepts
necessary to motivate and develop our mathematical model. We then introduce the human body
cell and its cell cycle. We continue further to briefly discuss how the tumor cell progresses. We
also discuss the types of genes, their corresponding network and functions at the R-checkpoint
in the literature review section. We then finally discuss about the new cancer subnetwork and
the objective of the study.
1.1 Background to Systems Biology
Systems biology is an approach by which biological questions are addressed through integrating
experiments, mathematical modeling and simulations [33]. The objective of systems biology
is the understanding of the dynamical interactions between components of a living system,
between living systems and their interactions with the environment. Systems biology deals
with the network of interacting proteins including (i) the reception and emission of chemical
signals within and between cells, (ii) the modulation and integration of signals which control
gene expression and ultimately cell function, and (iii) the control and coordination of metabolic
processes responsible for the intracellular bioenergetics and the biosynthesis. Modeling is not
the final goal of systems biology, but is a tool to enhance the understanding of the system, to
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Figure 1.1: Typical tissue microarchitecture showing epithelium separated from the stroma by
a basement membrane [10].
develop more directed experiments and finally to allow predictions [33]. Cell functions such as
cell differentiation, apoptosis, and the cell cycle are a prototypical focus of systems biology.
1.2 Human Body Cells and the Cell Cycle
The mammalian tissue structure is mainly composed of epithelial cells, the stroma, and the
mesenchymal cells [10]. The epithelium is composed of sheets of tightly adhered epithelial
cells which are separated by the basement membrane from the stroma. The stroma is a loose
connective tissue, which is interlaced by blood vessels, nerves, and lymphatic vessels. The
stroma includes the extracellular matrix (ECM) and the fibroblast of the cell which have a
vital role in the progression of the cancer cell. The mesenchymal cell is a combination of the
stroma and the muscle as shown in Figure 1.1. This complex structure of a cell is maintained
and regulated by a signal network that integrates genetic and proteomic information with
extracellular signals received through membrane-bound receptors [10].
1.2.1 Cell Population Dynamics
Each cell type population is regulated by balancing proliferation and apoptosis (we discuss
proliferation and apoptosis of a cell in the next section). When a differentiated cell dies, then a
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Figure 1.2: Phases in mammalian cell cycle [6].
somatic cell divides either symmetrically or asymmetrically. The division will give two new stem
cells in the first case while a stem cell and a progenitor cell in the latter case. The progenitor
cell either further divides or terminates its differentiation and is pushed to the correct position
to assume its normal function. All these processes are controlled and organized by intercellular
communication through biochemical signals and mechanics [10].
1.2.2 Cell Cycle, Proliferation and Apoptosis
The Eukaryotic cell cycle is a repeated sequence of events that enable the division of a cell into
two daughter cells. The cell cycle is classically divided into four phases: gap 1 (G1), synthesis
(S), gap 2 (G2), and mitosis (M). The diagramatic representation of the cell cycle is given in
Figure 1.2. There are specific activities which are carried out in each phase of the cell cycle
while the cell undergoes cell division. In the G1 phase of the cell cycle, the cell physically
grows, proteins are synthesized, new organelles are constructed, and the cell prepares for DNA
replication. In the following S phase the DNA is copied while in the G2 phase final preparations
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for cell division are made within the nucleus of the cell. In the last phase, M, the cell divides
into two daughter cells, which then begin a new cycle of division [5, 10, 18, 42].
The cell cycle contains numerous checkpoints that allow the cell to check for and repair DNA
damage, as well as to control or halt cell progression. At the R-checkpoint either the cell
commits to division and then progresses to the S phase or exits the cell cycle and enters the
quiescent state (G0). There are also checkpoints in between the G2 and the M phases to
detect and repair DNA damage. Cells that fail to repair DNA damage at such checkpoints
induce apoptosis (a cellular program which results in cell death) [10]. The cell cycle process
is orchestrated by production and balance of chemical signals (principally Cyclins and Cyclin-
dependent kinases (Cdks)) that activate and inhibit the cell cycle progression genes, which
form a complex and highly integrated network [10]. Basically, the cyclins (Cyclin E, cyclin D)
activate the signals while Cdks inhibits the cell cycle progression in the early stage of G1 by
forming the inactive form of Cyclin/Cdk complex. In this network, activating and inhibitory
signal molecules interact, forming positive feedback loop (when the signal transduction of one
step in the network facilitates the effect of the other signal transduction steps in the network)
and negative feedback loops (when the signal transduction of one step in the network hinders
effect on the other signal transduction steps in the network), which ultimately control the
dynamics of the cell cycle. The correct interpretation of growth and inhibitory signals is key
to maintaining the normal cell cycle process. The two types of genes which are particularly
important in regulating cell proliferation are oncogenes (which respond to or create growth
signals and promote cell cycle progression such as Cyclins and Cdks) and tumor suppressor
genes (TSGs) (which respond to inhibitory signals, retard or halt the cell cycle, or to ensure
DNA repair such as Cdk inhibitor families (P27Kip1, INK4)). If either of these genes or both
malfunction, then cancer initiation (carcinogenesis) will occur.
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1.3 The Biology of Cancer
Cancer occurs when defective genes cause cells to malfunction and interact with the body in an
aberrant manner by either increasing cell proliferation or decreasing cell apoptosis [2, 3, 10, 18].
The initiation of cancer may require the accumulation of multiple mutations which allow cells
to break out of the regulatory networks which ensure cooperation. Once a cancerous cell has
been created, it can undergo a process known as clonal expansion (gives rise to descendants by
cell division). This enables it to ignore growth-inhibiting signals from its neighbors, bypass its
internal controls and checkpoints, and form a colony of hyperproliferative aberrant cells.
1.3.1 Avascular, Vascular Growth and Metastasis
Once a tumor has established a foothold in its host tissue, in its early stage, it depends upon
the host vasculature for crucial substrates [10]. Substrates (such as oxygen, nutrient, and
growth factors) diffuse from the surrounding vascularized host tissue to the tumor and are
uptaken by proliferating tumor cells. The tumor cell interacts with the microenvironment of
the body cell both mechanically and chemically. It interacts with the body cell mechanically
by displacing and compressing the surrounding tissue including the basement membrane. It
also interacts chemically by secreting enzymes such as matrix metallo proteinases (MMPs) that
degrade ECM.
Many studies have reported that acidosis (a decreased microenvironmental pH level resulting
from anaerobic glycosis in hypoxic tumor cells) plays a role in tumor invasion by inducing
apoptosis in the surrounding epithelium and contributing to the ECM degradation [10, 21].
The ultimate result of cancer development is angiogenesis, where the tumor induces endothelial
cells to form a new vasculature that directly supplies the tumor cell. This supply of substrate
allows tumor cells to enter the blood supply, travel to a different site, and start growing in
different organs of the body. This process is referred to as metastasis [10].
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1.4 Literature Review
In mammals, entry into DNA replication is guarded by a cell cycle checkpoint called Restriction
(R)-checkpoint; a name proposed by Pardee [31]. Pardee conducted experiments to demonstrate
the R-checkpoint as a unique switching point between quiescent and proliferative states of
normal animal cells. A series of time-lapse video analyses has also been carried out by Zetterberg
and Larsson [41] to determine the precise location of the R-checkpoint. It occurs in the mid-
to-late G1 phase and marks the transition from mitogen-dependant to mitogen-independent
progression of the cell cycle [3]. The suggestion of Pardee [30, 31] that the R-checkpoint
has a vital importance in preventing malignant transformation has gained substantial support
from detailed genetic and molecular studies reported in recent years [3]. As a result, it has
been reported that the cell cycle is suspended at the R-checkpoint if the cell has not grown
sufficiently or possesses damaged DNA [2]. Once the cell does not qualify to progress to the S
phase, it resides in the quiescent state (G0 state) and is induced to re–enter the cell cycle by
mitogenic stimulation.
Many human cancers are known to originate from the malfunction of some genes at the R-
checkpoint such as transcriptional factors (E2F, C-Myc), cyclins (D, E), cyclin-dependent ki-
nases (Cdks), retinoblastoma protein (Rb), phosphatase Cdc25A and cyclin-dependent kinases
inhibitor P27Kip1 [2, 3, 18, 42]. D-type cyclins (D1, D2, D3) serve as targets of growth factors to
integrate extracellular signals into the core cell cycle regulators [18]. These cyclins are induced
to express in response to a variety of mitogenic signals and function as a regulatory subunit of
cyclin-dependent kinases (Cdk2, Cdk4, Cdk5, Cdk6). On the other hand, cyclin E (CycE) and
transcription factor E2F, are directly involved in the initiation of chromosomal DNA replication
[5, 18]. It has been claimed that almost all cancers are associated with one or more mutations
of genes at the R-checkpoint [29]. Examples include the following: (i) inactivation of Rb in
breast and cervical cancers and CML carcinoma, (ii) loss of cyclin-dependent kinase inhibitor
P16INK4a in pancreatic cancer, (iii) overexpression of CycD, CycE or Cdk4 in breast, head and
neck cancers, and (iv) loss of P27Kip1 in breast, prostate, colon, lung, and esophagus cancers
[39].
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Figure 1.3: Schematic model of part of the molecular signaling involved in the regulation of the
G1-to-S transition [3].
Given the complexity of the cell cycle, a logical approach is to model the G1-to-S and the
G2-to-M transitions separately. The biological reason for this approach is the existence of two
strong checkpoints: the R-checkpoint between the G1 and S phases and the G2/M-checkpoint
between the G2 and M phases. Mathematical models of regulation of the G1-to-S transition
have been developed and simulated [3, 15, 42], where the most detailed was developed by Aguda
and Tang [3].
Figure 1.3 summarizes the key interaction between the molecular signaling involved among
CycE/Cdk2, phosphatase Cdc25A, and Cdk inhibitor P27Kip1 during the G1-to-S transition,
which have been identified experimentally over the last two decades. All the solid arrows
(curves) which are numbered, represent the processes of transcriptional stimulations or activa-
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tions while the dashed arrows (curves) which are not numbered, represent the catalytic effect
of the regulators on the target processes. To give the general overview of the network and the
individual reaction in the network, we discuss each process as follows:
Process 1 represents the expression of P27Kip1 by mitogenic signals [16] which downregulation
is given by process 2 which is independent of the Cdk2 kinase activity and process 3 which
is dependent of the Cdk2 kinase activity [35]. Processes 4 and 5 represent the binding na-
ture of P27Kip1 with CycE/Cdk2 complex to form trimeric complex and its phosphorylation
respectively. In our model, to simplify the complexity, we assume that P27Kip1 binds only with
active CycE/Cdk2 (aCycE/Cdk2) and aCycE/Cdk2 is activated by only the active Cdc25A
(aCdc25A). The transcription factor E2F members (E2F1, E2F2, E2F3) have several impor-
tant target genes that drive cells into the S phase. Some of these are Cyclin E, C-Myc and
phosphatase Cdc25A [28]. Process 6 represents the E2F family dependent induction of inactive
CycE/Cdk2 complex while processes 7 and 8 represent the transcriptional induction of E2F
on C-Myc and the mitogenic stimulation of C-Myc on Cdc25A respectively [11]. Processes 9
and 11 represent the degradation of CycE/Cdk2 complex. Furthermore, it is also shown that
aCycE/Cdk2 complex induces its own degradation (curved dashed arrow in process 9) [32].
Process −10 represents the binding nature of CycE and Cdk2, which form an inactive complex
with Cdk2 phosphorylate at threonine 14 (Thr14) and tyrosine 15 (Tyr15). The activation of
CycE/Cdk2 complex by the catalytic effect (dephosphorylating of Thr14 and Tyr15) of Cdc25A
is represented by process 10. Process 12 and −12 represent the activation and inactivation
activity of phosphatase Cdc25A respectively. In the early G1 phase, PRb is in a hypophospho-
rylated (active) form and is able to bind the members of the E2F family of transcription factors.
The dashed arrow from aCycE/Cdk2 impinging on process 13 represents PRb phosphorylation.
In this process, PRb becomes hyperphosphorylated which leads to its activation and then the
release of E2F.
An important feature of the network in Figure 1.3 is the presence of positive feedback loops
such as the loop consisting of E2F, process 6, process 10 and the PRb-phosphorylation by
aCycE/Cdk2 complex. The other positive feedback loop in the network is composed of the











Figure 1.4: A cancer sub-network: All solid arrows represent either gene expression, or activa-
tion, or catalytic effect, or degradation effect by itself. The hammerheads refer to inhibition of
translation.
12 and process 10, which are reactions that catalyze process 12 and process 10 respectively
[17, 35]. These feedback loops account for the sudden increase in CycE/Cdk2 activity which is
assumed to stimulate entry into the S phase.
1.5 Cancer Sub-Network Considered in Our Model
Over the last two decades, mathematical models that provide insights into the dynamical
mechanisms underlying the cell cycle have been developed [1, 3, 13, 14, 15, 26, 27, 38, 42].
Cell cycle dynamics have been modeled as limit cycles [14, 15, 26, 42], bistable and excitable
systems [38, 42], and transient processes [1, 3, 42].
In our study, we have taken the approach of breaking down the regulatory network of the
G1-to-S transition into individual signaling modules, with components active cyclin E-Cdk2
(CycE/Cdk2) complex, active phosphatase protein Cdc25A, and Cdk inhibitor P27Kip1. To
simplify the network given in Figure 1.3, we merge the active and the inactive form as one
module. As a result we obtain the cancer subnetwork in Figure 1.4. The key components
of the network that generate a dynamic switching behavior associated with the R-checkpoint
include a positive feedback loop between CycE/Cdk2 complex and Cdc25A phosphates, along
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with a mutual negative interaction between the cyclin dependent kinases inhibitor P27Kip1 and
CycE/Cdk2 complex has been identified.
To the best of our knowledge, although the dynamics of the cell cycle during the G1-to-S
transition has been modeled and simulated, the search for a particular type of gene that needs
to be manipulated to treat cancer has yet to be concluded. Identifying the key regulatory
components during this process and finding out the parameters that need to be manipulated has
a vital importance in treating human cancer. In this study, we identify the crucial components
(phosphatase Cdc25A, CycE/Cdk2 complex, and P27Kip1) during the G1-to-S transition of the
cell cycle and the key parameters that need to be manipulated to retard the overexpression of
Cdc25A or CycE/Cdk2 complex or to reverse the downregulation of P27Kip1 level.
1.6 Objectives of the Study
The objectives of this study are (i) to identify some key regulatory components at the R-
checkpoint during the G1-to-S transition of the cell cycle, (ii) modeling the dynamics of their
concentrations, and (iii) to identify the parameter(s) need to be manipulated to hinder the
overexpression or to reverse the downregulation of the components during the cell cycle process.
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Chapter 2
An Overview of Dynamical Systems
In this chapter we discuss some model reaction mechanisms, which mirror a large number of real
reactions, and some general types of reaction phenomena with their corresponding mathematical
analyses. Understanding these reaction mechanisms is essential in constructing and analysing
our cancer sub-network model. We introduce the concept of nondimensionalisation and phase
plane analysis to obtain the qualitative behavior of the solution of both linear and nonlinear
systems. We further discuss the nonlinear (2-dimensional) systems of differential equations
along with the conditions for stability of their equilibrium points. We also discuss the Routh-
Hurwitz criteria to determine the stability nature of the equilibrium points for a nonlinear
system in higher dimensional space. Finally, we introduce the Bendixson condition to check
the existence of a limit cycle solution for a given system.
2.1 Basic Enzyme Reaction
Cells live in a complex environment and can sense different signals, including physical param-
eters (such as temperature, osmotic pressure), biological signaling from extracellular medium,
beneficial nutrients, and harmful chemicals. Cells respond to the information about damage
to DNA, membrane, or protein by producing appropriate proteins that act upon the internal
or external environment. This information-processing function, which determines the rate of
11
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Figure 2.1: The mapping between environment signals, transcription factors inside the cell,
and the genes that they regulate. The environmental signals activate the specific transcription
factor proteins. An activated transcription factor bind to specific target genes to change the
transcription rate at which mRNA is produced. The mRNA is then translated into protein
[33].
production of each protein is mainly carried out by transcription networks. Transcription fac-
tors are designed to transit rapidly between active and inactive molecular states, at a rate that
is modulated by a specific environment signal (input). Each active transcription factor can
bind the DNA to regulate the rate at which specific genes are transcribed. The genes which
are transcribed into mRNA is then translated into protein to act on the internal and external
environment of a cell.
Biochemical reactions are continually taking place in all living organisms and most of them
involve proteins called enzymes. Enzymes react selectively on definite compounds called sub-
strates. The enzymes are particularly important in regulating biochemical processes such as
activation or inhibition of chemical reactions. To understand their role we have to study the
kinetics, which is mainly the study of rates of reactions, the temporal behavior of various
reactants and the conditions which govern them [25].
One of the most basic enzymatic reactions, first proposed by Michaelis and Menten [24], involves
a substrate (S) reacting with an enzyme (E) to form a complex (SE) which in turn is converted
12








// P + E (2.1)
where k1, k−1 and k2 are nonnegative constant parameters associated with the rates of reaction.
The double arrow symbol ⇆ indicates that the reaction is reversible while the single arrow →
indicates that the reaction is only one way. Reaction (2.1) states that when one molecule of S
combines with one molecule of E, it forms one molecule of SE which eventually produces one
molecule of P and one molecule of E again. We denote the concentration of the reactants in
reaction (2.1) as follows:
[S] = s, [E] = e, [SE] = c, [P ] = p, (2.2)
where [ ] represents concentration of the substrate.
Definition 2.1.1. The Law of Mass Action states that the rate of a reaction is proportional
to the product of the concentrations of reactants [25]. 




= −k1es + k−1c, (2.3)
de
dt
= −k1es + (k−1 + k2)c, (2.4)
dc
dt




To make the mathematical formulation complete, we impose initial conditions on the system
of differential equations (2.3)–(2.6) which are given by
s(0) = s0, e(0) = e0, c(0) = 0, p(0) = 0. (2.7)
















once c(t) has been determined.
Moreover, in reaction (2.1), the enzyme E is a catalyst, which only facilitates the reaction, so
the total concentration of the enzyme (free and combined with substrate), is constant. This






= 0 for all t ≥ 0, (2.10)
which implies
e(t) + c(t) ≡ K for all t ≥ 0, (2.11)
where K is a constant real number. In particular,
e(0) + c(0) = K = e0. (2.12)
Therefore,
e(t) + c(t) = e0 for all t ≥ 0. (2.13)




= −k1e0s+ (k1s+ k−1)c, (2.14)
dc
dt
= k1e0s− (k1s+ k−1 + k2)c, (2.15)
with initial conditions
s(0) = s0, c(0) = 0. (2.16)
The standard approach to solve these equations is to assume that at the initial stage of the




Now, c can be expressed in terms of s from (2.15) as
c(t) =
k1e0s(t)













is called theMichaelis constant. Here, even though the assumption is reasonable, the expression
for c(t) does not satisfy the initial condition in (2.16). However, in many real reactions this
approximation is taken as a good approximation for c(t). We therefore continue to solve for
s(t) by substituting (2.19) into (2.14) and we obtain
ds
dt
















Now, using the initial condition s(0) = s0 and (2.23) we can solve for s(t) implicitly as
s(t) +Km log(s(t)) = s0 +Km log(s0)− k2e0t. (2.24)
Substituting (2.24) into (2.19) we obtain an expression for the complex c(t). Nonetheless this
raises a few important questions: i) how fast is the initial transient; ii) for what range of the
parameters does the approximation (2.19) and (2.24) hold; and iii) if the enzyme concentration
is not small compared to the concentration of the substrate, how do we deal with it?
In fact, there are two types of time scales in this system: one is the initial transient timescale
near t = 0 and the other is the longer time scale when the substrate changes significantly
during which the approximations (2.19) and (2.24) are reasonable. To analyze this problem
further, we need to nondimensionalise the system. To this end, we first introduce the concept
of nondimensionalisation in the next section.
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2.2 Nondimensionalisation
The form of a solution of a differential equation or a system of differential equations can depend
critically on the units one chooses for the various quantities involved. These choices can lead
to substantial problems when numerical approximation techniques such as Euler’s method are
applied. These difficulties can be controlled or overcome by a proper nondimensionalisation
procedure [40].
Definition 2.2.1. Nondimensionalisation is the partial or the full removal of units from an
equation involving physical quantities by suitable substitution of variables [40]. 
Though there are no fixed steps to be followed to nondimensionalise a given system, the fol-
lowing steps are useful [40]:
1) Identify all the independent and dependent variables;
2) Replace each of them with a quantity scaled relative to a characteristic unit of measure
to be determined;
3) Divide through by the coefficient of the highest order polynomial or by the coefficient of
the highest order derivative term;
4) Choose the characteristic unit for each variable so that the coefficients of as many terms
as possible become unity;
5) Rewrite the system of equations in terms of their new dimensionless quantities.
The last three steps are usually specific to the problem where nondimensionalisation is applied.
However, almost all systems require the first two steps to be performed.
Example 2.2.2. Here we nondimensionalise the first order differential equation with constant




+ bx = Af(x). (2.25)
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In this equation the independent variable is t, and the dependent variable is x. Setting x = x̃xc,






+ bxcx̃ = Af(τtc) = AF (τ). (2.26)










Thus, the coefficient of x̃ only contains one characteristic variable tc, and hence it is easier to





















Therefore, the final dimensionless equation in this case becomes completely independent of any
parameters with units and is given by
dx̃
dτ
+ x̃ = F (τ). (2.32)









, p(0) = p0. (2.33)
We give a step by step approach to nondimensionalise this initial value problem. In this model
p is the dependent and t is the independent variables. We take each variable and create a new
variable by dividing the combination of parameters that has the same dimension in order to



























































with u(0) = p0
A
. Thus, if we introduce another new parameter γ = p0
A
, then the initial condition
becomes u(0) = γ.
Therefore, (2.33) has two dimensionless variables u, τ and three dimensionless parameters α,
β, γ which are combinations of original parameters. This simplified form of the equation has
reduced the number of parameters from five to three, which makes the analysis of the equation
simpler. 
Now, to analyze the quasi-steady state of the system (2.14)–(2.15), the standard way of nondi-
mensionalising the system is to set





















which is a reasonable nondimensionalisation if ǫ ≪ 1. Substituting (2.39) and (2.40) into
(2.14)–(2.15) together with (2.16) gives the dimensionless system
du
dτ














Figure 2.2: Schematic behavior of the solution of the system for dimensionless substrate (u),
substrate-enzyme complex (v) and free enzyme (e/e0 = 1 − v) concentrations as functions of
dimensionless time τ [25].
with
u(0) = 1, v(0) = 0. (2.43)
With the solutions u(τ), v(τ) we immediately obtain e and p from (2.13) and (2.9) respectively.
Moreover, from the reaction (2.1), which converts S into a product P , we obtain the steady state
u = 0 and v = 0; that is, both the substrate and the substrate-enzyme complex concentrations
are zero. We can also see that the time evolution of the nonlinear system (2.41)–(2.42) near
τ = 0 is governed by du
dτ
< 0 and dv
dτ
> 0 (because v ≈ 0). As a result u decreases from u = 1




= 0). From (2.41), u is still decreasing at the
point v = u
u+k
. After v has reached its maximum then it decreases ultimately to zero as u does
for all t. The dimensional enzyme concentration e(t) first decreases from e0 and then increases
again to e0 as t → ∞. Typical solutions of the system (2.41)–(2.42) are illustrated in Figure
2.2.
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2.3 Phase Diagrams and Linear Systems
In this section, we define the phase diagram and discuss some basic concepts pertinent to an
analysis of linear systems.
2.3.1 Definitions
Consider a system of autonomous ordinary differential equations
ẋ = f(x) (2.44)
with x : ℜ → ℜn and f : ℜn → ℜn. The space of all possible values of x is called the phase
space of the system (2.44) [19].
In this brief introduction to the phase space, we shall only concentrate on the cases ℜ and ℜ2.
In general, the phase space could be a subset of ℜn, or a differentiable manifold. The velocity
field f(x) is equal to the velocity ẋ of any solution curve x(t), and is therefore called the phase
velocity vector field associated to the system (2.44). The trajectory of a solution x of (2.44) is
the set of all points reached by x(t) for some value of t.
Definition 2.3.1. A phase diagram of (2.44) is the phase space ℜn with trajectories of (2.44)
drawn through each point [19]. 
Thus the phase diagram shows all the possible trajectories of an autonomous differential equa-
tion. However, in practice we only sketch a few trajectories. Points where the vector field f
vanishes play an important role in understanding the qualitative behavior of solutions of the
system (2.44).
Definition 2.3.2. An equilibrium point is a point where the vector field f vanishes [19]. 
Note that every equilibrium point (also called fixed point or the steady state) x∗ is itself a
trajectory of a constant solution
x(t) ≡ x∗ (2.45)
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since
ẋ = f(x) = 0. (2.46)
Definition 2.3.3. An equilibrium point x∗ is called stable if for every ǫ > 0 there exist a δ > 0
so that [20]
|x0 − x∗| < δ ⇒ |x(t)− x∗| < ǫ, t ≥ 0 (2.47)
for every solution x of (2.44) with x(0)=x0. 
Intuitively, an equilibrium point is called stable if, when we start close enough to it, we stay
close to it. An equilibrium point is called unstable if it is not stable.
Definition 2.3.4. An equilibrium point x∗ is called attracting if there is a δ > 0 so that [20]
|x0 − x∗| < δ ⇒ x(t) → x∗, as t → ∞ (2.48)
for every solution x of (2.44) with x(0)=x0. 
In one-dimensional systems attracting points are stable, but there exist attracting points which
are not stable in higher dimensional systems.
Definition 2.3.5. An equilibrium point x∗ is called asymptotically stable if it is stable and
attracting [20]. 
Example 2.3.6. Consider the equation [37, p 39]
ẋ = k1ax− k2x2, (2.49)
where k1 and k2 are positive rate constants and a and x are some chemical concentrations. The
equilibrium points of (2.49) are obtained by setting
k1ax− k2x2 = 0, (2.50)
which implies




To identify the stability of these equilibrium points, we sketch ẋ versus x in Figure 2.3.
Therefore, x = 0 is an unstable equilibrium point whereas x = k1a
k2
, which is positive, is a
stable equilibrium point. 
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Figure 2.3: The phase diagram of the system (2.49).
2.3.2 Linear Systems
In this section, we briefly introduce linear homogeneous n−dimensional systems and then we
investigate the properties of the equilibrium point using linear homogeneous two dimensional
systems.
Consider a linear homogeneous system [19, p 164]
























and A is a real constant n × n matrix. Notice that x = 0 is a solution of the system of
differential equations (2.52). In fact, x = 0 is the only equilibrium solution for the system
where A is assumed to be a nonsingular matrix. The eigenvalues of the n×n matrix A are the
roots of the characteristic polynomial
|A− λI| = 0, (2.54)
where I is the identity matrix of order n.
To explore the type of equilibrium points and their associated phase diagrams, we consider
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linear homogeneous two dimensional systems
dx
dt
= ax(t) + by(t), (2.55)
dy
dt
= cx(t) + dy(t), (2.56)












Let λ1 and λ2 be the eigenvalues of the real matrix A defined in (2.58). Then, the general






 = c1v1 exp(λ1t) + c2v2 exp(λ2t), (2.59)
where c1 and c2 are arbitrary constants and v1, v2 are eigenvectors of A corresponding to λ1
and λ2 respectively. We consider the different possibilities of λ1 and λ2 case by case as follows
[20, p 226]:
Case 1: λ1, λ2 are real and distinct:
(a) λ1 < λ2 < 0: Suppose we have c1 > 0, c2 = 0. Then the trajectory corresponding to this
solution will point along the ray in the direction of v1, with the arrow pointing towards to
the origin. If c1 < 0, c2 = 0, the trajectory will point along the ray in the direction of −v1
with arrow pointing towards the origin. Similarly, if c1 = 0, c2 > 0 (< 0), the trajectory
will point along the ray in the direction of v2, (−v2) with the arrow pointing towards
to the origin. For t ≫ 0 and both c1 and c2 different from zero, the c2v2 exp(λ2t) term
will dominate and so the direction of approach to (0, 0) will be parallel to the direction
of v2. Similarly, when t → −∞ the first term c1v1 exp(λ1t) dominates, and the direction
of the trajectory will approach that of v1. The phase diagram will have the form shown
in Figure 2.4a. In this case the equilibrium point (0, 0) is called a stable node.
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(a) Phase diagram when λ1 < λ2 < 0. (b) Phase diagram when 0 < λ1 < λ2.
Figure 2.4: Phase diagram of the system (2.57) for cases (a) and case (b).
(b) 0 < λ1 < λ2: In this case all the trajectories will move out from the equilibrium point
(0, 0). As t → ∞ the c2v2 exp(λ2t) term will dominate and so the direction of any
trajectory will approach that of v2. As t → −∞ the c1v1 exp(λ1t) term will dominate
and so the direction of any trajectory will approach that of v1. The phase diagram will
have the form shown in Figure 2.4b. In this case the equilibrium point (0, 0) is called
unstable node.
Example 2.3.7. For the system [19, p 201]
ẋ = −2x+ y, (2.60)
ẏ = x− 2y, (2.61)







x = Ax. (2.62)
λ is an eigenvalue of A if and only if
(−2− λ)2 − 1 = 0. (2.63)
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Figure 2.5: Phase diagram of the system (2.60)–(2.61).
Therefore, the eigenvalues are
λ1 = −3 and λ2 = −1. (2.64)




























The phase diagram of the system (2.60)–(2.61) is shown in Figure 2.5. 
(c) λ1 < 0 < λ2: In this case, if c1 = 0, the trajectory is outward along the ray in the
direction of c2v2. If c2 = 0, the trajectory is inward along the ray in the direction of c1v1.
As t → ∞ the solution is dominated by c2v2 exp(λ2t) and when t → −∞ the solution is
dominated by c1v1 exp(λ1t). Thus the phase diagram has the form shown in Figure 2.6.
In this case the equilibrium point (0, 0) is called a saddle point. It is always unstable
(except strictly along v1) because any perturbation from (0, 0) grows exponentially.
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Figure 2.7: Phase diagram of the system (2.57) when α 6= 0.
Case 2: λ1, λ2 are complex: λ1= λ̄2 = α + iβ, β 6= 0.
In this case the general solution (2.59) involves exp(αt) and exp(±iβt) which implies an oscil-
latory approach to (0, 0).
(a) α 6= 0: In this case we have a spiral which is stable if α < 0 and unstable if α > 0 (see
Figure 2.7).
(b) α = 0: In this case the phase curves are circles. This equilibrium point is called a centre
and it is illustrated in Figure 2.8. The equilibrium point (0, 0) is stable. However, since





Figure 2.8: Phase diagram of the system (2.57) when α = 0.
Example 2.3.8. For the system [19, p 203]
ẋ = x+ y, (2.67)
ẏ = 4x+ y, (2.68)
(0, 0) is the only equilibrium point of the given system. Furthermore, the system (2.67)–(2.68)







x = Ax. (2.69)
Then λ is eigenvalue of A if and only if
(1− λ)2 − 4 = 0. (2.70)
Thus,
λ1 = −1 and λ2 = 3. (2.71)




























The possible phase diagram of the system (2.67)–(2.68) is shown in Figure 2.9. 
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Figure 2.9: Phase diagram of the system (2.67)–(2.68).
2.4 Nonlinear Systems, Routh-Hurwitz and Bendixson
Conditions
In this section, we first briefly introduce a nonlinear autonomous system of differential equa-
tions and discuss how to use the phase plane method to obtain qualitative information about
the behaviour of a nonlinear system without actually solving the system. We then introduce
Routh-Hurwitz conditions for stability of equilibrium points in higher dimensional space. We
further discuss the Bendixson negative criterion for the existence of limit cycle solutions for the
dynamical system in the specified domain.
2.4.1 Linearization
Consider a nonlinear system of differential equations
ẋ = f(x), (2.74)
where f : ℜn → ℜn is nonlinear map and continuously differentiable on its domain. Such
systems can not in general, be solved exactly. Hence, one can learn much about the qualitative
behavior of the solutions by linearizing about the equilibrium points [20, p 219]. Unlike the
linear homogeneous systems we discussed in section 2.3, the nonlinear autonomous system of
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differential equations (2.74) may have several equilibrium points. We specifically discuss how
to linearise the nonlinear system at the equilibrium point different from the origin later in our
discussion in two dimensional space. We first focus on the linearisation of our system (2.74)
























x = x∗ + h, (2.76)
where h is a small perturbation from the equilibrium point x∗. Then we approximate f by the
linear term in the Taylor expansion
f(x∗ + h) = f(x∗) +Df(x∗)h+O(h2), (2.77)



























Since ḣ = ẋ− ẋ∗ = ẋ, (2.74) has the linear approximation
ḣ = Df(x∗)h. (2.79)
Thus, the nature of equilibrium points of a linear system of differential equations can be applied
to equilibrium points in a nonlinear system.




















and f and g are smooth functions such that f(a, b) = 0 = g(a, b) with (a, b) an equilibrium
point. To linearize the system (2.80)–(2.81), we approximate the system close to the equilibrium
point (a, b). Setting x = a + ξ, y = b + η and taking a Taylor expansion of f(x, y) and g(x, y)
we obtain
f(x, y) = f(a, b) + ξ
∂f
∂x



























g(x, y) ≈ ξ ∂g
∂x




if ξ and η are very small. Noting that
ẋ = ξ̇ and ẏ = η̇, (2.85)
















The system (2.86)–(2.87) is called the linearized form of the system (2.80)–(2.81). The phase
diagram of the linearized system close to (0, 0) gives a good approximation to the phase dia-
gram of the nonlinear system. Furthermore, the solutions of the system (2.80)–(2.81) and the
solutions of the system (2.86)–(2.87) behave similarly close to the equilibrium point (a, b).




















If Re(λ), Re(µ) 6= 0 and λ 6= µ, then (a, b) is the same type of equilibrium point for both systems
(2.80)–(2.81) and (2.86)–(2.87). 
Possible types of equilibrium points are stable (or unstable) nodes, stable (or unstable) spirals,
or saddle points.
Remark 2.4.2. For those cases which are not included in Theorem 2.4.1, we have the following
remarks.
a) If λ = iω, then (a, b) is a centre for the linearised system but may become a stable or
unstable spiral for the nonlinear system.
b) If λ = µ with λ, µ < 0, then (a, b) is a stable improper node or stable star for the linearised
system, but it may be either the same or a stable node or a stable spiral point for the
nonlinear system.
c) If λ = µ with λ, µ > 0, then (a, b) is unstable improper node or unstable star for the
linearised system, but may be either the same or an unstable node or an unstable spiral
point for the nonlinear system [20]. 
Example 2.4.3. Consider the nonlinear system [19, p 206]
ẋ = 2y + xy, (2.89)
ẏ = x+ y. (2.90)
The equilibrium points of the system (2.89)–(2.90) are (0, 0) and (−2, 2). The linearized system







x = Ax. (2.91)















Figure 2.10: Phase diagram of the system (2.89)–(2.90).
respectively. Hence using Theorem 2.4.1, the equilibrium point (0, 0) is a saddle point for both







x = Ax. (2.93)














respectively. Now using Theorem 2.4.1, (−2, 2) is an unstable node for the system (2.93) and
the system (2.89)–(2.89). A possible phase diagram for the system (2.89)–(2.90) is given in
Figure 2.10.
2.4.2 Routh-Hurwitz Conditions and Bendixson Negative Criterion
Linear stability of the systems of ordinary differential equations which arise in reaction kinetics
systems are determined by the nature of the roots of the characteristic polynomial. The stability





where A is the matrix of the linearized form of the nonlinear reaction system. However, the
techniques we developed so far are restricted only to 2-dimensional space systems. As a result,
we further discuss the Routh-Hurwitz conditions for stability analysis in higher dimensional
systems.
The Routh-Hurwitz conditions give the necessary and sufficient conditions for all roots of the
characteristic polynomial (with real coefficients) to lie in the left half of the complex plane.
These criteria are used to determine the asymptotic stability of the equilibrium point for a
nonlinear system of differential equations. There are many equivalent forms of stating these
criteria, one of which is stated in Theorem 2.4.4.
Theorem 2.4.4. (Routh-Hurwitz Criteria) [12] Given the polynomial
P (λ) = λn + a1λ
n−1 + · · ·+ an,
where the coefficients ai, i = 0, 1, 2, . . . n are real constants, define the n Hurwitz matrices as


































a1 a3 a5 . . .
1 a2 a4 . . .
0 a1 a3 . . .
. . . . . . . . .













with aj = 0 if j > n. All the roots of the polynomial P (λ) are negative or have negative real
parts if and only if the determinant of all Hurwitz matrices, denoted by
























































a1 a3 a5 . . .
1 a2 a4 . . .
0 a1 a3 . . .
. . . . . . . . .

















where k = 1, 2, . . . , n, are positive. 
When n = 2, the Routh-Hurwitz criteria simplify to















= a1a2 > 0, (2.100)
or equivalently a1 > 0 and a2 > 0. For characteristic polynomials of degree n = 3, 4 and 5, the
Routh-Hurwitz criteria are summarized as
n = 3 : a1 > 0, a3 > 0, and a1a2 > a3. (2.101)










(a1a4 − a5)(a1a2a3 − a23 − a21a4) > a5(a1a2 − a3)2 + a1a25. (2.103)
In the analysis of nonlinear systems, equilibrium points are not the only interesting points for
which one may want to search. Limit cycles of the systems are also of interest.
Definition 2.4.5. A limit cycle is an isolated closed trajectory in the phase plane of the given
system [19, 20, 37]. 
If all neighbouring trajectories approach the limit cycle, we say the limit cycle is stable (Figure
2.11a); otherwise the limit cycle is unstable (Figure 2.11b), or in some cases, half-stable (Figure
2.11c). Stable limit cycles are very important scientifically– they model systems that exhibit self
sustained oscillations. There are many examples that could be given, we mention only a few:
the beating of the heart; daily rhythms in human body temperature and hormone secretion;
and chemical reactions that oscillate spontaneously.
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Figure 2.11: Different types of limit cycles.
Figure 2.12: Equilibrium points and their stability nature of the system (2.104).
Example 2.4.6. Consider the system (in polar coordinate form) [37, p 143]
ṙ = r(1− r2), (2.104)
θ̇ = 1, (2.105)
where r ≥ 0. The radial and angular dynamics are uncoupled and so can be analyzed separately.
From (2.104), we obtain r = 0 is an unstable equilibrium point and r = 1 is a stable as shown
in Figure 2.12. Hence, in the phase plane, all trajectories (except r = 0) approach the unit
circle r = 1 monotonically. Since the motion in the θ-direction is simply rotation at a constant
angular velocity, we see that all trajectories spiral asymptotically toward the limit r = 1 as
shown in Figure 2.13. 
The criterion to identify the nonexistence of a limit cycle for a given dynamical system is stated
as follows:
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Figure 2.13: Limit Cycle of the system (2.104)–(2.105).
Theorem 2.4.7. (Bendixson Negative Criterion) [20] Consider a nonlinear dynamical system
dx
dt
= F (x, y), (2.106)
dy
dt
= G(x, y), (2.107)
where F and G are continuously differentiable functions on some simply connected domain,
D ⊆ ℜ2. If






is of one sign in D, there cannot be a limit cycle (closed orbit) contained within D. 
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Chapter 3
Mathematical Analysis of the Cancer
Sub-Network Model
In this chapter, we discuss the formulation of the cancer subnetwork model, which is shown in
Figure 1.4 and the nondimensionalization of the model. We further discuss the steady states
and their stability behavior.
3.1 Key Assumptions
Based on the experimental evidence summarized in the introduction chapter, we make assump-
tions upon which our mathematical model is based in Table 3.1. Some assumptions are well
grounded in the literature (such as assumptions 1− 5) while others remain to be tested.
3.2 Formulation of the Model
As we described in the introduction chapter, human cancers occur due to the dysfunction of
some genes at the R-checkpoint during the cell cycle. Among these genes CycD, CycE, Cdk2,
Cdk4, Cdk6, phosphatase Cdc25A, E2F, Rb, and P27Kip1 are the key regulators in the control
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Table 3.1: Key assumptions in our model
1 Constant stimulation rate of phosphatase Cdc25A and [3]
merging iCdc25A and aCdc25A
2 Constant stimulation rate of Cdk inhibitor P27Kip1 [3, 36, 42]
3 Constant stimulation rate of CycE/Cdk2 and [9, 42]
merging iCycE/Cdk2 and aCycE/Cdk2
4 Mutual activation between Cdc25A and CycE/Cdk2 [2, 3, 34, 42]
5 Mutual inhibition between CycE/Cdk2 and P27Kip1 [2, 3, 42]
[9, 18, 36]
6 Only CycE/Cdk2 inhibits P27Kip1 to be tested
7 First order degradation rates of Cdc25A, CycE/Cdk2, and P27Kip1 to be tested
8 Negligible effect of multisite phosphorylation of Cdc25A and CycE/Cdk2 to be tested
9 Negligible effect of free and inactive form of CycE, Cdk2, and CycE/Cdk2 to be tested
of the G1-to-S transition. It has been also experimentally shown that there is mutual acti-
vation between phosphatase Cdc25A and CycE/Cdk2 complex while mutual inhibition occurs
between CycE/Cdk2 complex and Cdk inhibitor P27Kip1 [1, 2]. To understand the dynamics
of these gene concentrations, a mathematical model of a hypothetical molecular mechanism
for the regulation of CycE/Cdk2 activity, phosphatase Cdc25A and Cdk inhibitor P27Kip1 is
developed as given in (3.3)–(3.5). This is done by translating the interaction mechanisms in
Figure 1.4 into a set of autonomous nonlinear ordinary differential equations (ODEs) using
the standard principles of biochemical kinetics [24, 38]. For the sake of simplicity we denote
the concentration of each gene as [Cdc25A] = x, [CycE/Cdk2] = y, and [P27Kip1] = z. We
first discuss the nature of the degradation rate of the concentrations of the components. We
assume each concentration degrades at a rate proportional to its concentration. For instance,





as shown in Figure 3.1. We also assume the inhibition relationship between CycE/Cdk2 complex
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Figure 3.1: The degradation effect on the dynamics of Cdc25A with different initial conditions.







where k is the inhibition coefficient of z to y, and has units of concentration, ρ is production
rate and n a parameter which measures the steepness of the function h(z). In our study we will
use the values (ρ = 1µM/min and n = 1) unless otherwise indicated. Depending on the values
of k and z, the dynamics of the CycE/Cdk2 complex could be different as shown in Figure 3.2.
We then generate our cancer sub-network model as
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k = 0.01, z = 10−4
k = 1, z = 1
k = 1.5, z = 10
k = 5, z = 100




= α+ k1y − ax, (3.3)
dy
dt






= γ − cz + σk4
k4 + y
, (3.5)
where α and β are the constitutive protein expressions for the Cdc25A and CycE/Cdk2 complex
due to signal transduction pathways stimulated by growth factors present in the extracellular
medium (such as transcriptional factors E2F and C-Myc) respectively. The parameter γ rep-
resents the y independent constitutive transcription of z such as mitogenic signal stimulation.
Parameters k1 and k2 are positive constant parameters which measure the efficiency of acti-
vation of y by x and x by y respectively (i.e. the mutual activation phenomenon). On the
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other hand, k3 and k4 are positive inhibition coefficients and have unit of concentrations which
measure the efficiency of the inhibition of z to y and y to z respectively (the mutual inhibition
phenomenon) where as ρ and σ are the production rates of y by z and z by y respectively. For




regulate the inhibition nature of z to y and y to z respec-
tively, whereas the terms k2x and k1y are rates of x-induced transcription of y and y-induced
transcription of x respectively. They are assumed to be first order in x and in y for the sake of




, where ϕ and φ are produc-
tion rates. The terms −ax, −by, and −cz are a first order protein degradation with fixed rate
coefficients a, b, and c due to ubiquitin-proteasome pathways.
3.3 Nondimensionalisation of the Model
Before analyzing the model, it is essential to express it in nondimensional terms. Doing so has
some advantages. For example, the units used in the analysis are then unimportant and helps
to reduce the number of parameters in dimensionless groups which determine the dynamics of
the model. In any model there are usually different ways of nondimensionalisation possible and
this model is no different. Consider the model (3.3)–(3.5) with nonnegative initial conditions




































































































































































we obtain the nondimensionalised form of the model (3.3)–(3.5) as
du
dτ
= α′(1 + v)− a′u = f(u, v, w), (3.16)
dv
dτ




= g(u, v, w), (3.17)
dw
dτ
= γ′ − w + q
k′4 + v
= h(u, v, w), (3.18)
with nonnegative initial conditions u(0) = u0, v(0) = v0 and w(0) = w0.
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3.4 Steady State of the Model
The steady state(s), (u∗, v∗, w∗), are obtained by equating the right hand side of each equation
(3.16)–(3.18) to zero. From (3.18) we obtain
w∗ =
γ′v∗ + (γ′k′4 + q)
v∗ + k′4
. (3.19)




























(1 + γ′)v∗ + (1 + γ′)k′4 + q
= 0, (3.22)
which implies
[(1 + γ′)v∗ + (k′4 + k
′
4γ
′ + q)][(α′β ′ − a′b′)v∗ + (β ′a′ + β ′α′)] + a′k′1v∗ + a′k′1k′4 = 0. (3.23)
Thus
[(α′β ′ − a′b′)(1 + γ′)](v∗)2 + [(k′4 + k′4γ′ + q)(α′β ′ − a′b′) + (β ′a′ + β ′α′)(1 + γ′)
+ a′k′1]v
∗ + (β ′a′ + β ′α′)(k′4 + k
′
4γ
′ + q) + a′k′1k
′
4 = 0. (3.24)
Setting
k = (α′β ′ − a′b′)(1 + γ′), (3.25)
l = (α′β ′ − a′b′)(k′4 + k′4γ′ + q) + (β ′a′ + β ′α′)(1 + γ′) + a′k′1, (3.26)
m = (β ′a′ + β ′α′)(k′4 + k
′
4γ
′ + q) + a′k′1k
′
4, (3.27)
we can rewrite (3.24) as
k(v∗)2 + lv∗ +m = 0. (3.28)
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Since all the parameter values are positive (to be biologically meaningful), the constant term














However, we are only interested in the positive solution of v∗. Thus we need to identify the
condition(s) for which (3.28) has positive solutions. To do this we first calculate l2 and 4km:
l2 = [(α′β ′ − a′b′)(k′4 + k′4γ′ + q) + (β ′a′ + β ′α′)(1 + γ′) + a′k′1]2,
= [(α′β ′ − a′b′)(k′4 + k′4γ′ + q)]2 + [(β ′a′ + β ′α′)(1 + γ′)]2 + [a′k′1]2
+ 2(α′β ′ − a′b′)(k′4 + k′4γ′ + q)(β ′a′ + β ′α′)(1 + γ′)
+ 2(α′β ′ − a′b′)(k′4 + k′4γ′ + q)(a′k′1) + 2(β ′a′ + β ′α′)(1 + γ′)(a′k′1), (3.31)
and
4km = 4[(α′β ′ − a′b′)(1 + γ′)][(β ′a′ + β ′α′)(k′4 + k′4γ′ + q) + a′k′1k′4],




= 4(α′β ′ − a′b′)(1 + γ′)(β ′a′ + β ′α′)(k′4 + k′4γ′ + q) + 4(α′β ′ − a′b′)(k′4 + k′4γ′)
(a′k′1). (3.32)
Then
l2 − 4km = [(α′β ′ − a′b′)(k′4 + k′4γ′ + q)]2 + [(β ′a′ + β ′α′)(1 + γ′)]2 + [a′k′1]2
− 2(α′β ′ − a′b′)(1 + γ′)(β ′a′ + β ′α′)(k′4 + k′4γ′ + q)
− 2(α′β ′ − a′b′)(k′4 + k′4γ′)a′k′1 + 2(α′β ′ − a′b′)(a′k′1q)
+ 2(β ′a′ + β ′α′)(1 + γ′)(a′k′1). (3.33)
By adding
2(α′β ′ − a′b′)(1 + γ′)(β ′a′ + β ′α′)(k′4 + k′4γ′ + q), (3.34)
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and
2(α′β ′ − a′b′)(k′4 + k′4γ′ + q)(a′k′1), (3.35)
into (3.33) and subtracting the same term from it we obtain a new expression for l2 − 4km
given by
l2 − 4km = l2 + 4(a′b′ − α′β ′)[∆], (3.36)
where
∆ = (k′4 + k
′
4γ















l2 + 4(a′b′ − α′β ′)[∆]
2k
. (3.39)
For v∗ to be a real solution,
l2 + 4(a′b′ − α′β ′)[∆] ≥ 0. (3.40)
Furthermore, for v∗ to be real and positive it also depends on the value of
a′b′ − α′β ′. (3.41)
We consider different cases to identify the condition(s) for the existence of positive values of
v∗.
Case 1: a′b′ − α′β ′ > 0








Case 2: a′b′ − α′β ′ < 0
This time k > 0. Therefore, there is no positive solution for v∗.




l2 + 4(a′b′ − α′β ′)[∆]
2k
, (3.43)
as the only positive solution provided that
a′b′ − α′β ′ > 0. (3.44)
To express this condition in terms of the original parameters, we use (3.15) and after substitution
we obtain












β > 0, (3.45)
which implies
ab > k1k2. (3.46)
Therefore, the positive steady state(s), (u∗, v∗, w∗), can be calculated from
w∗ =














a′b′ − α′β ′ > 0. (3.50)
Theorem 3.4.1. If a′b′ − α′β ′ > 0, then there is a positive steady state (u∗, v∗, w∗) given by
(3.47)–(3.49) for all τ > 0.
Biologically, the condition a′b′ − α′β ′ > 0 (or equivalently ab − k1k2 > 0) means that the
concentration of each component in the system (3.3)–(3.5) stabilizes at the positive values of
(u∗, v∗, w∗) as given in (3.47)–(3.49) provided the combined degradation rate of Cdc25A and
CycE/Cdk2 complex is greater than their combined activation rate. The model also produces
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some of the fundamental features of CycE/Cdk2 complex and phosphatase Cdc25A. According
to (3.48), the steady state of phosphatase Cdc25A and CycE/Cdk2 complex increases or de-
creases in the same direction. This model prediction agrees with the observations that the levels
of Cdc25A and CycE are both increased in various tumors [8, 21, 39]. The model also clarifies
the interpretation of Aguda and Tang [3], Kato [18], and Zhilin et al.[42] that an increase in
CycE/Cdk2 level correlates with an increase in the level of Myc and E2F, both of which induce
transcriptional signals to Cdc25A and results in promoting cell proliferation.
3.5 Stability Analysis of the Model
To determine the stability of the steady state (u∗, v∗, w∗), we need to calculate the eigenvalues



































































−a′ − λ α′ 0
























(−b′ − λ)(−1− λ)− k
′
1q
(1 + w∗)2(k′4 + v
∗)2
]




a′λ2 + a′(b′ + 1)λ+ a′b′ − a
′k′1q
(1 + w∗)2(k′4 + v
∗)2




(1 + w∗)2(k′4 + v
∗)2)
]
+ α′β ′ + α′β ′λ = 0, (3.56)
which implies
λ3 + (a′ + b′ + 1)λ2 +
[
b′ + a′(b′ + 1)− α′β ′ − k
′
1q
(1 + w∗)2(k′4 + v
∗)2
]
λ+ a′b′ − α′β ′
− a
′k′1q





′ + b′ + 1, (3.58)
a2 = b
′ + a′(b′ + 1)− α′β ′ − k
′
1q




′b′ − α′β ′ − a
′k′1q
(1 + w∗)2(k′4 + v
∗)2
, (3.60)
we obtain the characteristic polynomial
λ3 + a1λ
2 + a2λ+ a3 = 0. (3.61)
To analyze the stability of the steady states (as our model is higher than 2-dimensional space),
we use the Routh-Hurwitz conditions in the next section.
3.5.1 Asymptotic Stability
Using the Routh-Hurwitz conditions for stability, the steady state (u∗, v∗, w∗) is asymptotically
stable (which means Re(λ) < 0 for all roots λ of (3.61)) if the following conditions are satisfied:
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Condition 1:
D1 = a1 = a
′ + b′ + 1 > 0, (3.62)



















(a′ + b′ + 1)(b′ + a′(b′ + 1)− α′β ′ − k
′
1q
(1 + w∗)2(k′4 + v
∗)2
)− a′b′ + α′β ′
+
a′k′1q
(1 + w∗)2(k′4 + v
∗)2
> 0. (3.64)
This can be written as
(a′ + b′ + 1)(a′ + b′) + (a′ + b′)(a′b′) + (a′ + b′)(−α′β ′) + (−b
′ − 1)k′1q
(1 + w∗)2(k′4 + v
∗)2
> 0, (3.65)
which is also equivalent to
(a′ + b′)(a′ + b′ + a′b′ + 1) > (a′ + b′)(α′β ′) +
(b′ + 1)k′1q




(a′ + b′)(a′ + b′ + a′b′ + 1) > (a′ + b′)(α′β ′) +
(b′ + 1)k′1q




(1 + w∗)2(k′4 + v
∗)2 = [(1 + γ′)(k′4 + v
∗) + q]2. (3.68)
Condition 3:
D3 = a3 > 0, (3.69)
which implies
a′b′ > α′β ′ +
a′k′1q





a′b′ > α′β ′ +
a′k′1q
[(1 + γ′)(k′4 + v
∗) + q]2
. (3.71)
Therefore, for the steady state (u∗, v∗, w∗) to be asymptotically stable the conditions (3.62),
(3.67) and (3.71) must hold.
3.5.2 Limit Cycles
Since periodicity is an inherent phenomenon in cell division cycle, we examine the existence of
a limit cycle for our model using the Bendixson criterion. To this end, we take an arbitrary
but fixed concentration of P27Kip1, say P , and using (3.3)–(3.4) we obtain
dx
dt
= α + k1y − ax = F (x, y), (3.72)
dy
dt
= β + k2x− by +
k3
k3 + P
= G(x, y). (3.73)






= −(a+ b) < 0, (3.74)
for all t > 0.
Therefore, our model predicts that we cannot have a limit cycle solution for the molecular
network containg CycE/Cdk2 complex and phosphatase Cdc25A if we keep the concentration
of P27Kip1 constant (which could be maintained by adjusting the mitogenic stimulation and
the degradation rate of P27Kip1).
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Chapter 4
Numerical Simulations and Results of
the Model
In this chapter, we discuss the various results we obtained from the mathematical analysis
along with the numerical results. The ODEs in the model (3.3)–(3.5) are provided as input
to MatLab [23] (a simulation software) using the package Ode45 to carry out the numerical
simulations (refer to the appendix for the details of the MatLab code). Our results from
the numerical simulations also confirm analyses in the literature. Many parameter values are
obtained from the literature while a few are chosen by trial and error to fit the basic physiological
behavior of the cell cycle process. However, in all our numerical simulation we use the value of
ρ = σ = 1µM/min unless otherwise indicated in the respective figure.
4.1 The Role of Phosphatase Cdc25A
Phosphatase Cdc25A is a key regulator of the G1-to-S transition and is highly expressed in
several types of cancers [21]. Overexpression of Cdc25A accelerates the G1-to-S transition while
its downregulation delays the G1-to-S transition. In this section we examine only the dynamics
of Cdc25A by keeping the concentration of the CycE/Cdk2 complex constant (because the
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P27Kip1 equation can be decoupled from the Cdc25A equation). We identify the important
parameters that need to be controlled to keep the protein concentration of phosphatase Cdc25A
at normal levels.
Using an arbitrary but fixed value of y, say K, and (3.3) we obtain the positive stable equilib-





Since we assume that Cdc25A has only one phosphorylation site, regardless of the parameter
choices the steady state is always stable as shown in Figure 4.1. This result agrees with the
result of Zhilin et al. [42] under only one site for Cdc25A phosphorylation. The results in
Figure 4.1 (a)-(d) show the effect of the Cdc25A degradation rate on the equilibrium point. As
the degradation rate decreases, the value of the equilibrium point increases. Overexpression of
phosphatase Cdc25A such as in Figure 4.1(d) leads to a quicker entry into S phase, geonomic
instability, and tumorigenesis [21, 36, 42]. Our model also shows that downregulation of Cdc25A
can be obtained by changing the synthesis rate, α, of Cdc25A as shown in Figure 4.2. To adjust
the synthesis rate, α, one can adjust the concentrations of the transcriptional factors Myc and
E2F using therapeutic drugs that target these transcription factors.
4.2 The Regulation of CycE/Cdk2 Complex
Proper CycE/Cdk2 regulation is important for the normal cell division cycle. Insufficient
CycE/Cdk2 complex results in cell arrest in the G1 phase, whereas overexpression of CycE/Cdk2
leads to premature entry into the S phase. When the CycE/Cdk2 expression increases, it may
stay high. However, unless the concentration of CycE/Cdk2 is downregulated for normal DNA
replication, the overexpression of CycE/Cdk2 (though it is stable) might be the cause for ge-
nomic instability and then for tumorigenesis [8, 18, 42]. The subnetwork in our model generates
an abrupt change in the activity of CycE/Cdk2 for a certain choice of parameter values. In
fact, the core of this sharp spike is the positive feedback loop between the Cdc25A and the
CycE/Cdk2 complex, along with the mutual negative interaction between CycE/Cdk2 and
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Figure 4.1: The effect of degradation rate on the dynamics of Cdc25A concentration taking
y = 10−6. In all cases, the solution curves converge to the equilibrium points. Equilibrium
points: x∗ = 0.0500, 0.10000, 1.0000, 10.0000 for Figures 4.1(a), (b), (c), and (d) respectively.
Initial Conditions: x(0) = 2× 10−5, 0.25, 0.75, 2.55.
P27Kip1 as shown in Figure 4.3. A distinctly sharp pulse of CycE/Cdk2 activity is generated
at lower levels of P27Kip1 and then regulated by the higher level of P27Kip1 which confirms the
results in [3, 18, 42]. We further examine the dynamics of CycE/Cdk2 and P27Kip1 by keeping
Cdc25A constant. The timing of the increase in CycE/Cdk2 activity coincides with the decay
of P27Kip1 as shown in Figure 4.4. Our simulation result agrees with the results of Aguda and
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Figure 4.2: The effect of synthesis rate of Cdc25A on the value of equilibrium point. Initial
values: x(0) = 2× 10−5, 0.25, 0.75, 2.55, and y = 0.06. Equilibrium point: x∗ = 0.0620
Tang [3] and Zhilin et al. [42].
4.3 The role of P27Kip1
Generating a pulse of CycE/Cdk2 activity before the S phase entry requires more components
of the network in Figure 1.3 to be included as well as choosing appropriate parameter values
(especially for CycE and E2F degradation rates) which will affect the Cdc25A degradation
rate. However, in our model, the cancer subnetwork (Figure 1.4) and the nonlinear system of
differential equations (3.3)–(3.5) are used to carry out a series of simulations to see the effect of
different levels of P27Kip1. The results are shown in Figure 4.5. The simulations show that the
initial P27Kip1 level influences the switch on time (the time required by the CycE/Cdk2 solution
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Figure 4.3: The effect of constantly stimulating P27Kip1 on the dynamics of CycE/Cdk2 with
different initial conditions. Initial conditions: y(0) = 10−6, 0.1, 5 and x = 2× 10−5. Parameter
values: k2 = 0.2, k3 = 0.1, k4 = 0.2, b = 0.001, c = 0.001.
curve to cross and to remain above the solution curve of P27Kip1) for CycE/Cdk2 activity. The
lower the P27Kip1 level, the shorter the time needed to activate CycE/Cdk2. However, in this
particular simulation we also observed that Cdc25A and CycE/Cdk2 complex seem increasing
indefinitely as long as we keep P27Kip1 level below some threshold value.
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Figure 4.4: The effects of P27Kip1 on the peak activity of CycE/Cdk2 with different initial
conditions. y(0) = 0.06, z(0) = 10−6, 5, x = 0.01. Parameter values: k2 = 0.2, k3 = 0.1,
k4 = 0.2, b = 0.1, c = 0.01.
In this simulation, the positive feedback loop between CycE/Cdk2 and Cdc25A is also reflected.
When the concentration level of CycE/Cdk2 rises (because of the lower level of P27Kip1), the
concentration level of phosphatase Cdc25A starts to rise and requires a shorter time to reach
the switch on time.
56
4.4 The Dynamics of the Model
In the simulation of the model that takes into account all the molecular concentrations of
Cdc25A, CycE/Cdk2 and P27Kip1, we obtain results that support our analytical solutions. In
this simulation, as long as we keep the condition (3.46) (which is the condition for the existence
of a positive equilibrium point as shown (3.47)–(3.49)), all the solution curves converge to
the equilibrium point (Figures 4.6a–b). Moreover, our model shows that the downregulation
of P27Kip1 can be achieved through either cutting off (reducing) the mitogenic stimulation of
P27Kip1 or increasing its degradation rate (Figure 4.6b). In these simulations (Figures 4.6a–b),
even though we have three different initial conditions for each concentration, the solution curves
of CycE/Cdk2 complex and Cdc25A coincides immediately from the beginning. Moreover, in
Figure 4.6b the concentration of P27Kip1 is almost identical to zero (z∗ = 0.0198).
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Figure 4.5: The effect of P27Kip1 levels on the activity of Cdc25A and CycE/Cdk2. Initial levels
of P27Kip1: a) 10−3 b) 4.5 c) 10. Parameter values: k1 = 0.01, a = 0.1, k2 = 0.2, b = 0.002,
k3 = 0.1, c = 10
−3, k4 = 0.3. Initial conditions: x = 0.01, y = 10
−4.
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(a) Parameter value: c = 10−2































(b) Parameter value: c = 1
Figure 4.6: Model dynamics for different initial conditions. Common parameter values for
(a) and (b): k1 = 0.01, a = 0.06, k2 = 0.02, b = 0.08, k3 = 0.1, k4 = 0.3. Initial condi-
tions: (x(0), y(0), z(0))=(10−2, 10−5, 10−3), (0.02, 0.06, 1.2),(0.7, 0.27, 2.5). Equilibrium points:




5.1 Summary of the Results
The cancer subnetwork presented in our study is grossly simplified from what is currently
known about the molecular and the gene interactions of oncogenes and tumor suppressor genes.
However, the full cancer network during the cell cycle process is too complex to be modeled
computationally at once. To model the cancer network we started with a simple model that
captured the basic features of the network. This model can be later made more realistic.
In this study, a core cancer subnetwork consisting of Cdc25A, CycE/Cdk2 complex and P27Kip1
was identified and a new mathematical model was also developed. Mathematical analyses and
numerical simulations were carried out and the results are consistent with various results in
the literature. One of the aims of this study was to see whether there is a critical parameter
of this subnetwork which is responsible for the sudden increase of the CycE/Cdk2 complex
concentration. Indeed, our model simulation result showed that (keeping the other parameter
values fixed) the subnetwork generates a peak value of CycE/Cdk2 activity when the degrada-
tion rate of the complex is generally less than 0.001 min−1 (Figure 4.3). Our model results also
suggest that CycE/Cdk2 regulates P27Kip1. The CycE/Cdk2 activity reverses the inhibitory
effect that P27Kip1 has on cell cycle progression at the R checkpoint and initiates a pathway
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that leads to the elimination of P27Kip1 from the cell (Figure 4.6b). On the other hand, we also
show that the downregulation of P27Kip1 is prevented by decreasing the catalytic activity of
the CycE/Cdk2 complex which could be adjusted by changing the E2F transcription rate, by
increasing the degradation rate of CycE/Cdk2 or by decreasing the constant simulation rates of
Cdc25A and CycE/Cdk2 (Figure 4.6a). A recent study [42] showed that the failure to degrade
CycE stabilized the CycE/Cdk2 complex at high level which led to tumorigenesis, similar to
the overexpression of Cdc25A. The regulation of CycE/Cdk2 is essential to prevent cells from
becoming cancerous. Our model results show that the high degradation rate of CycE/Cdk2
makes the concentration of CycE/Cdk2 very low and a low degradation rate keeps the con-
centration of CycE/Cdk2 complex high. This could be taken as a therapeutic target gene for
cancer treatment.
Phosphatase Cdc25A promotes cell cycle progression and is overexpressed in numerous rapidly
dividing cancer cells. An increasing number of studies have shown a positive correlation be-
tween overexpression of Cdc25A and cancer [21, 29]. Our model results also suggest that the
overexpression of Cdc25A leads to the increase in the activity of CycE/Cdk2 (Figure 4.6b)
which subsequently lead to an uncontrolled proliferation of cells.
5.2 Remarks and Future Work
Although our results are consistent with many experimental results and confirm results from
the literature, there are some limitations in our study. The first limitation is that no clear data
on the rate parameters are available which makes the investigation of the numerical simulation
difficult. Secondly, there are more regulatory interaction components such as PRb, E2F family,
CycD/Cdk4 and their multisite phosphorylation properties which highly influence the activity
of Cdc25A and CycE/Cdk2 complex. These were not incorporated directly into our model.
Nevertheless, we obtained promising results that motivate us to modify our model so as to
further explore the dynamics of the cell cycle and to identify some therapeutic strategy to treat
cancer.
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In our model, we used linear degradation terms. We wish to modify these terms of our model










which may express the real biological protein concentration degradation phenomenon more
accurately. We also used a reciprocal function to express the inhibition relationship between
CycE/Cdk2 and P27Kip1. It is our intention to modify the inhibition relationship using a




where k, q and m are Hill coefficients [33]. We hope the oscillatory nature of the solution can
be achieved by choosing an appropriate value of the Hill exponent m along with adding some
more key regulatory components (such as PRb, E2F, and/or the INK4 CDK inhibitor family)
into our cancer sub-network. This is the subject of future work.
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Appendix A
MatLab Codes Used in our Numerical
Simulations
A.1 The Dynamics of Phosphotase Cdc25A
This MatLab code illustrates the evolution of the phosphotase Cdc25A concentration
keeping CycE/Cdk2 constant.
Clear up the previous definitions.
clear all;
close all;





Codes that solve the system numerically using the package Ode45.
%%disp(’The problem is being solved using ode45...’)
%%[tt,xx]=ode45(@(t,x)cdc25a,[tmin,tmax],initial conditions);
Codes that solve the system graphically.
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%%disp(’plotting solution is being carried out...’)
%%plot(tt,xx(:,1))




Codes that label axes and produce multiple plots.
%%xlabel(Time [min])
%%ylabel(Cdc25A concentration [$\mu$M])
%%hold on, hold off
Published with MATLAB 7.11
A.2 Effect of P27Kip1 on the Dynamics of CycE/Cdk2
complex
The MatLab code that simulates the effect of continous stimulation of P27$^{Kip1}$
on the CycE/Cdk2 complex.
Codes that clear up the previous definition.
clear all % clear previously defined variable






















%%axis([zmin zmax 0 20])
%%hold on and hold off
%%disp(’Finished’)
Published with MATLAB 7.11
A.3 Dynamics of CycE/Cdk2 complex and P27Kip1 Con-
centrations
MatLab code that illustrates the dynamics of CycE/Cdk2 complex and P27$^{Kip1}$.























%%axis([0 tmax 0 20])
%%legend(’CycE/Cdk2’,’P27$^{Kip1}$’)
%disp(’Finished’)
Published with MATLAB 7.11
A.4 The Dynamics of the Model
























%%hold on and hold off
Codes for string and numeric changing.





%%axis([0 tmax 0 50]);
%%legend(’Cdc25A’,’CycE/Cdk2’,’P27$^{Kip1}$’)
%%disp(’Finished’)
Published with MATLAB 7.11
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